Skip Header

 

1 - 25 of 64 results for author:"Fletcher C."Drop in Literature Citations

Customize display Download...

Page of 3 | Next »

Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.

Hornick J.L., Dal Cin P., Fletcher C.D.

Am. J. Surg. Pathol. 33:542-550(2009) · Mapped (5)

Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.

Liegl B., Hornick J.L., Corless C.L., Fletcher C.D.

Am. J. Surg. Pathol. 33:437-446(2009) · Mapped (4)

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Heinrich M.C., Maki R.G., Corless C.L., Antonescu C.R., Harlow A., Griffith D., Town A., McKinley A., Ou W.B., Fletcher J.A. et al.

J. Clin. Oncol. 26:5352-5359(2008) · Mapped (6)

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

Heinrich M.C., Owzar K., Corless C.L., Hollis D., Borden E.C., Fletcher C.D., Ryan C.W., von Mehren M., Blanke C.D., Rankin C. et al.

J. Clin. Oncol. 26:5360-5367(2008) · Mapped (6)

Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.

Vermi W., Lonardi S., Bosisio D., Uguccioni M., Danelon G., Pileri S., Fletcher C., Sozzani S., Zorzi F., Arrigoni G. et al.

J. Pathol. 216:356-364(2008) · Mapped (2)

Platelet factor 4 mediates inflammation in experimental cerebral malaria.

Srivastava K., Cockburn I.A., Swaim A., Thompson L.E., Tripathi A., Fletcher C.A., Shirk E.M., Sun H., Kowalska M.A., Fox-Talbot K. et al.

Cell Host Microbe 4:179-187(2008) · Mapped (3)

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies.

Miki T., Zwingman T.A., Wakamori M., Lutz C.M., Cook S.A., Hosford D.A., Herrup K., Fletcher C.F., Mori Y., Frankel W.N. et al.

Neuroscience 155:31-44(2008) · Mapped (16)

EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.

Antonescu C.R., Dal Cin P., Nafa K., Teot L.A., Surti U., Fletcher C.D., Ladanyi M.

Genes Chromosomes Cancer 46:1051-1060(2007) · UniProtKB (2) · Mapped (24)

BAFF and MyD88 signals promote a lupuslike disease independent of T cells.

Groom J.R., Fletcher C.A., Walters S.N., Grey S.T., Watt S.V., Sweet M.J., Smyth M.J., Mackay C.R., Mackay F.

J. Exp. Med. 204:1959-1971(2007) · Mapped (8)

Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.

Chai J., Lu X., Godfrey V., Fletcher C., Roberts C.W., Van Dyke T., Weissman B.E.

Cancer Res. 67:3002-3009(2007) · Mapped (6)

Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism.

Saitoh A., Fletcher C.V., Brundage R., Alvero C., Fenton T., Hsia K., Spector S.A.

J. Acquir. Immune Defic. Syndr. 45:280-285(2007) · Mapped (5)

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis.

Savage K., Lambros M.B., Robertson D., Jones R.L., Jones C., Mackay A., James M., Hornick J.L., Pereira E.M., Milanezi F. et al.

Clin. Cancer Res. 13:90-101(2007) · Mapped (6)

Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.

Fletcher C.A., Sutherland A.P., Groom J.R., Batten M.L., Ng L.G., Gommerman J., Mackay F.

Eur. J. Immunol. 36:2504-2514(2006) · Mapped (2)

Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels.

Luvisetto S., Marinelli S., Panasiti M.S., D'Amato F.R., Fletcher C.F., Pavone F., Pietrobon D.

Neuroscience 142:823-832(2006) · Mapped (8)

Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.

Anderson P.L., Lamba J., Aquilante C.L., Schuetz E., Fletcher C.V.

J. Acquir. Immune Defic. Syndr. 42:441-449(2006) · Mapped (42)

The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.

Carrasco D.R., Fenton T., Sukhdeo K., Protopopova M., Enos M., You M.J., Di Vizio D., Divicio D., Nogueira C., Stommel J. et al.

Cancer Cell 9:379-390(2006) · Mapped (19)

ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract.

Hirsch M.S., Dal Cin P., Fletcher C.D.

Histopathology 48:569-578(2006) · Mapped (13)

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.

Ribaudo H.J., Haas D.W., Tierney C., Kim R.B., Wilkinson G.R., Gulick R.M., Clifford D.B., Marzolini C., Fletcher C.V., Tashima K.T. et al.

Clin. Infect. Dis. 42:401-407(2006) · Mapped (5)

The transcriptional landscape of the mammalian genome.

Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C. et al.

Science 309:1559-1563(2005) · UniProtKB (27,424) · Mapped (12,732)

BAFF augments certain Th1-associated inflammatory responses.

Sutherland A.P., Ng L.G., Fletcher C.A., Shum B., Newton R.A., Grey S.T., Rolph M.S., Mackay F., Mackay C.R.

J. Immunol. 174:5537-5544(2005) · Mapped (25)

An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children.

Saitoh A., Singh K.K., Powell C.A., Fenton T., Fletcher C.V., Brundage R., Starr S., Spector S.A.

AIDS 19:371-380(2005) · Mapped (8)

tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors.

Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D.M., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P. et al.

Proc. Natl. Acad. Sci. U.S.A. 102:407-412(2005) · UniProtKB (1) · Mapped (10)

Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs).

Duensing A., Joseph N.E., Medeiros F., Smith F., Hornick J.L., Heinrich M.C., Corless C.L., Demetri G.D., Fletcher C.D., Fletcher J.A.

Cancer Res. 64:5127-5131(2004) · Mapped (3)

The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.

Panagopoulos I., Storlazzi C.T., Fletcher C.D., Fletcher J.A., Nascimento A., Domanski H.A., Wejde J., Brosjo O., Rydholm A., Isaksson M. et al.

Genes Chromosomes Cancer 40:218-228(2004) · UniProtKB (1)

Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).

Dahlen A., Fletcher C.D., Mertens F., Fletcher J.A., Perez-Atayde A.R., Hicks M.J., Debiec-Rychter M., Sciot R., Wejde J., Wedin R. et al.

Am. J. Pathol. 164:1645-1653(2004) · Mapped (18)

Page of 3 | Next »